PMDA — authorised 12 December 2020
- Marketing authorisation holder: TEIJIN PHARMA LIMITED
- Status: approved
PMDA authorised Somatuline Depot on 12 December 2020
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 12 December 2020.
TEIJIN PHARMA LIMITED holds the Japanese marketing authorisation.